Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Yang Y, Zhang Y, Zhao D, Li X, et al. A Novel PRKAR1A::MET Fusion Dramatic Response to Crizotinib in a Patient with Unresectable Lung Cancer. Clin Lung Cancer 2022 Oct 14. pii: S1525-7304(22)00211.
PMID: 36323591


Privacy Policy